メタゲノムシーケンス市場規模、シェア、成長分析、製品タイプ別、技術別、用途別、エンドユーザー別、地域別 - 業界予測、2024～2031年

メタゲノムシーケンスの世界市場規模は、2022年に18億米ドルと評価され、2023年の21億2,000万米ドルから2031年には76億8,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは17.5％で成長する見通しです。

世界のメタゲノムシーケンス市場は、複雑な微生物群集とそれが人間の健康、生態系、産業機能に及ぼす影響を理解することへの関心の高まりに後押しされ、力強い成長を遂げています。主なアプリケーションには、臨床診断、農業調査、環境モニタリング、創薬などがあります。次世代シーケンシング技術の採用とシーケンシングコストの低下が、学術機関、研究機関、製薬会社の市場拡大を促進しています。さらに、感染症の罹患率の上昇や個別化医療の需要が、市場の継続的な活性化に寄与しています。しかし、データ解析、標準化、プライバシー問題などの課題が、このダイナミックな分野の継続的成長にリスクをもたらす可能性があります。全体として、メタゲノムシーケンスは様々な科学分野において重要な役割を果たすと考えられます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析
• ケーススタディ

メタゲノムシーケンス市場規模：製品タイプ別およびCAGR（2024～2031年）

• 市場概要
• 機器
  • シーケンシングシステム
  • サンプル調製システム
• 消耗品
  • 試薬とキット
  • マイクロプレート
• ソフトウェア
  • データ分析ソフトウェア
  • ストレージおよび管理ソフトウェア

メタゲノムシーケンス市場規模：技術別およびCAGR（2024～2031年）

• 市場概要
• 16S Rrnaシーケンシング
• ショットガンメタゲノムシーケンス
• 全ゲノム配列解析
• メタトランスクリプトミクス

メタゲノムシーケンス市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 臨床診断
  • 感染症の診断
  • がんの診断
• 創薬
  • マイクロバイオーム分析
  • 病原体の特定
• 環境用途
  • 土壌微生物分析
  • 水マイクロバイオーム分析
• 産業用途
  • バイオ燃料生産
  • バイオレメディエーション

メタゲノムシーケンス市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 製薬・バイオテクノロジー企業
  • 医薬品開発
  • 品質管理
• 学術調査機関
  • 基礎調査
  • トランスレーショナル調査
• 病院・クリニック
  • 診断検査室
  • 臨床調査

メタゲノムシーケンス市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN N.V.（Netherlands）
• PerkinElmer, Inc.（USA）
• Oxford Nanopore Technologies Ltd.（UK）
• Pacific Biosciences of California, Inc.（USA）
• BGI Group（China）
• PSomagen, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Macrogen, Inc.（South Korea）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Zymo Research Corporation（USA）
• NuGEN Technologies, Inc.（USA）
• Takara Bio Inc.（Japan）
• Swift Biosciences, Inc.（USA）
• Hamilton Company（USA）

結論と推奨事項

Global Metagenomic Sequencing Market size was valued at USD 1.8 billion in 2022 and is poised to grow from USD 2.12 billion in 2023 to USD 7.68 billion by 2031, growing at a CAGR of 17.5% during the forecast period (2024-2031).

The global metagenomic sequencing market is witnessing robust growth, propelled by the surging interest in understanding complex microbial communities and their effects on human health, ecosystems, and industrial functions. Key applications include clinical diagnostics, agricultural research, environmental monitoring, and drug discovery. The adoption of next-generation sequencing technologies and falling sequencing costs are catalyzing market expansion among academic institutions, research bodies, and pharmaceutical companies. Furthermore, the rising incidence of infectious diseases and the demand for personalized medicine are contributing to continued market vitality. However, challenges such as data analysis, standardization, and privacy issues may pose risks to ongoing growth in this dynamic sector. Overall, metagenomic sequencing is poised to play a crucial role in various scientific fields.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metagenomic Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metagenomic Sequencing Market Segmental Analysis

Global Metagenomic Sequencing Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into instruments, consumables and software. Based on technology, the market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and metatranscriptomics. Based on application, the market is segmented into clinical diagnostics, drug discovery, environmental applications and industrial applications. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and hospitals & clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Metagenomic Sequencing Market

One significant factor fuelling the global metagenomic sequencing market is the rising demand for personalized healthcare. As advancements in metagenomic sequencing allow for an in-depth analysis of the microbial communities inhabiting an individual's body, healthcare professionals can gain critical insights into a person's unique microbiome and its implications for overall health. This information is essential in crafting tailored treatment strategies, assessing disease risk, and selecting the most effective therapies. The growing awareness of the microbiome's influence on health, coupled with the promising advantages posed by metagenomic sequencing, has significantly increased the appetite for this innovative technology in the medical field.

Restraints in the Global Metagenomic Sequencing Market

One of the primary challenges facing the global metagenomic sequencing market is the prohibitive costs linked with the technology. The intricate processes involved in metagenomic sequencing-including sample preparation, data analysis, and interpretation-necessitate the use of advanced equipment and highly skilled personnel. These factors contribute to substantial expenses for both sequencing and the accompanying bioinformatics analysis, thus hindering widespread implementation, particularly in resource-constrained environments. Furthermore, the extensive volume of data produced from metagenomic sequencing demands advanced computational resources for efficient analysis, which exacerbates the overall financial burden associated with the technology and limits its accessibility.

Market Trends of the Global Metagenomic Sequencing Market

The global metagenomic sequencing market is experiencing robust growth, propelled by increasing demand for personalized medicine and improved disease characterization. The advancement of sequencing technologies combined with sophisticated bioinformatics tools has enhanced data analysis capabilities, fostering wider adoption across clinical and research domains. Additionally, the utilization of metagenomic sequencing in environmental monitoring and agricultural applications is contributing to market expansion. Collaborative efforts between research institutions and biotechnology firms are driving innovation, attracting significant investment. However, challenges relating to data management, regulatory compliance, and standardization are critical considerations that could impact the market's trajectory and necessitate ongoing attention for sustained advancement.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Metagenomic Sequencing Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Instruments
  • Sequencing Systems
  • Sample Preparation Systems
• Consumables
  • Reagents & Kits
  • Microplates
• Software
  • Data Analysis Software
  • Storage & Management Software

Global Metagenomic Sequencing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• 16S Rrna Sequencing
• Shotgun Metagenomic Sequencing
• Whole-Genome Sequencing
• Metatranscriptomics

Global Metagenomic Sequencing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Diagnostics
  • Infectious Disease Diagnosis
  • Cancer Diagnosis
• Drug Discovery
  • Microbiome Analysis
  • Pathogen Identification
• Environmental Applications
  • Soil Microbiome Analysis
  • Water Microbiome Analysis
• Industrial Applications
  • Biofuel Production
  • Bioremediation

Global Metagenomic Sequencing Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Drug Development
  • Quality Control
• Academic & Research Institutes
  • Basic Research
  • Translational Research
• Hospitals & Clinics
  • Diagnostic Laboratories
  • Clinical Research

Global Metagenomic Sequencing Market Size & CAGR (2024-2031)

• North America (Product Type, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuGEN Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swift Biosciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations